Published in Am J Epidemiol on July 15, 1994
Varicella-zoster virus. Clin Microbiol Rev (1996) 3.03
Varicella vaccination--a critical review of the evidence. Arch Dis Child (2001) 1.52
Varicella vaccination. Recommendation statement from the Canadian Task Force on Preventive Health Care. CMAJ (2001) 1.48
Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease. BMC Infect Dis (2010) 1.41
Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel. J R Soc Interface (2011) 1.01
The burden of varicella in Germany. Potential risks and economic impact. Eur J Health Econ (2004) 1.00
Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting? Hum Vaccin Immunother (2013) 0.96
Varicella zoster virus infections in Canadian children in the prevaccine era: A hospital-based study. Can J Infect Dis (1997) 0.93
Mass vaccination to control chickenpox: the influence of zoster. Proc Natl Acad Sci U S A (1996) 0.90
Vaccination and clinical severity: is the effectiveness of contact tracing and case isolation hampered by past vaccination? Int J Environ Res Public Health (2013) 0.89
Deterministic SIR (Susceptible-Infected-Removed) models applied to varicella outbreaks. Epidemiol Infect (2007) 0.82
Emerging, evolving, and established infectious diseases and interventions. Science (2014) 0.80
Modelling the effects of population structure on childhood disease: the case of varicella. PLoS Comput Biol (2011) 0.78
An outbreak of varicella among schoolchildren in Taipei. BMC Public Health (2011) 0.78
Impact on immunization of seasonal cycle of chickenpox. Eur J Epidemiol (2000) 0.77
Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England. Vaccine (2013) 0.76
Clinical benefits of routine varicella vaccination for adults. Hum Vaccin Immunother (2015) 0.75
Pasteurized milk as a vehicle of infection in an outbreak of listeriosis. N Engl J Med (1985) 11.94
Intussusception among infants given an oral rotavirus vaccine. N Engl J Med (2001) 5.33
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
Study designs for dependent happenings. Epidemiology (1991) 3.58
Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants. Pediatrics (1999) 3.49
Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis (1999) 3.48
Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27
Invasive group B streptococcal disease in adults. A population-based study in metropolitan Atlanta. JAMA (1991) 3.09
Does influenza vaccination prevent asthma exacerbations in children? J Pediatr (2001) 2.89
Intramuscular injections within 30 days of immunization with oral poliovirus vaccine--a risk factor for vaccine-associated paralytic poliomyelitis. N Engl J Med (1995) 2.81
Rehospitalization for respiratory syncytial virus among premature infants. Pediatrics (1999) 2.73
Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children. Lancet (1991) 2.64
Interrupted care. The effects of paging on pediatric resident activities. Am J Dis Child (1992) 2.60
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
Molecular epidemiology of diphtheria in Russia, 1985-1994. J Infect Dis (1996) 2.12
Direct and indirect effects in vaccine efficacy and effectiveness. Am J Epidemiol (1991) 2.08
The Vaccine Adverse Event Reporting System (VAERS). Vaccine (1994) 2.02
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA (1985) 1.91
Acquired immunodeficiency syndrome in low-incidence areas. How safe is unsafe sex? JAMA (1987) 1.81
Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics (1996) 1.79
Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994. J Clin Microbiol (1995) 1.76
Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis (2000) 1.76
Pertussis hospitalizations and mortality in the United States, 1985-1988. Evaluation of the completeness of national reporting. JAMA (1992) 1.74
Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis (1999) 1.61
Haemophilus influenzae invasive disease in the United States, 1994-1995: near disappearance of a vaccine-preventable childhood disease. Emerg Infect Dis (1998) 1.57
Childhood upper respiratory tract infections: to what degree is incidence affected by day-care attendance? Pediatrics (1987) 1.57
Epidemiological features of pertussis in the United States, 1980-1989. Clin Infect Dis (1992) 1.55
Interpretation and estimation of vaccine efficacy under heterogeneity. Am J Epidemiol (1992) 1.50
Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clin Immunol Immunopathol (1986) 1.44
Comment: ethical dilemmas in worldwide polio eradication programs. Am J Public Health (1997) 1.44
Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis (2000) 1.41
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr (1986) 1.40
Septic arthritis due to Micrococcus luteus. J Rheumatol (1986) 1.39
Are we ready for diphtheria? A report from the Diphtheria Diagnostic Workshop, Atlanta, 11 and 12 July 1994. J Infect Dis (1995) 1.32
Mumps outbreak in a highly vaccinated population. J Pediatr (1991) 1.30
Vaccine prevention of Haemophilus influenzae type b disease: past, present and future. Pediatr Infect Dis (1986) 1.27
Small animals are not susceptible to human immunodeficiency virus infection. J Gen Virol (1987) 1.24
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23
Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis (1995) 1.21
Evaluation of a method for detecting aberrations in public health surveillance data. Am J Epidemiol (1993) 1.21
A randomized comparison of home visits and hospital-based group follow-up visits after early postpartum discharge. Pediatrics (2001) 1.19
Disease eradication as a public health strategy: a case study of poliomyelitis eradication. Bull World Health Organ (2000) 1.18
Assessment of vital statistics and surveillance data for monitoring tetanus mortality, United States, 1979-1984. Am J Epidemiol (1990) 1.18
Mumps transmission in hospitals. Arch Intern Med (1990) 1.14
National immunization days: state of the art. J Infect Dis (1997) 1.12
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Preventing rubella: assessing missed opportunities for immunization. Am J Public Health (1987) 1.11
Tetanus surveillance--United States, 1989-1990. MMWR CDC Surveill Summ (1992) 1.09
Paralytic poliomyelitis in Romania, 1984-1992. Evidence for a high risk of vaccine-associated disease and reintroduction of wild-virus infection. Am J Epidemiol (1994) 1.09
A large outbreak of mumps in the postvaccine era. J Infect Dis (1988) 1.08
Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J Infect Dis (2000) 1.07
Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable disease. JAMA (1988) 1.07
Immunizations in college health: the remaining tasks. J Am Coll Health (1987) 1.06
Beta agonists, inhaled steroids, and the risk of intensive care unit admission for asthma. Eur Respir J (2001) 1.04
Tetanus surveillance--United States, 1995-1997. MMWR CDC Surveill Summ (1998) 1.03
Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child (1992) 1.01
Pertussis surveillance--United States, 1989-1991. MMWR CDC Surveill Summ (1992) 1.01
Diphtheria toxoid vaccine effectiveness: A case-control study in Russia. J Infect Dis (2000) 1.00
Clinical performance and effect on treatment rates of latex agglutination testing for streptococcal pharyngitis in an emergency department. Pediatr Infect Dis (1987) 0.99
Control of epidemic group A meningococcal meningitis in Nepal. Int J Epidemiol (1987) 0.98
Parents' preferences for outcomes associated with childhood vaccinations. Pediatr Infect Dis J (2000) 0.97
Pertussis in Missouri: evaluation of nasopharyngeal culture, direct fluorescent antibody testing, and clinical case definitions in the diagnosis of pertussis. Clin Infect Dis (1993) 0.97
Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention. JAMA (1985) 0.96
Defining surrogate serologic tests with respect to predicting protective vaccine efficacy: poliovirus vaccination. Ann N Y Acad Sci (1995) 0.96
Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J (2001) 0.96
Overview of neonatal listeriosis. Clin Invest Med (1984) 0.95
Respiratory diphtheria in the United States, 1980 through 1995. Am J Public Health (1998) 0.95
Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough. Clin Infect Dis (1995) 0.95
Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis (2000) 0.94
Blood lead testing by pediatricians: practice, attitudes, and demographics. Am J Public Health (1997) 0.94
Changing epidemiology of mumps and its impact on university campuses. Pediatrics (1989) 0.93
Risk factors for pertussis in young infants during an outbreak in Chicago in 1993. Clin Infect Dis (1996) 0.93
Intussusception among recipients of rotavirus vaccine: reports to the vaccine adverse event reporting system. Pediatrics (2001) 0.92
Effectiveness of the pertussis vaccination program as determined by use of the screening method: United States, 1992-1994. J Infect Dis (1997) 0.92
Waving goodbye to measles. Nature (2001) 0.91
A new epidemiologic and laboratory classification system for paralytic poliomyelitis cases. Am J Public Health (1989) 0.89
Tetanus surveillance--United States, 1991-1994. MMWR CDC Surveill Summ (1997) 0.89
Novel dihydrofolate reductases isolated from epidemic strains of trimethoprim/sulfamethoxazole-resistant Shigella sonnei. J Infect Dis (1990) 0.89
Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am J Gastroenterol (2001) 0.87
Diphtheria surveillance and control in the Former Soviet Union and the Newly Independent States. J Infect Dis (2000) 0.87
Costs of otitis media in a managed care population. Pediatr Infect Dis J (2000) 0.87
Myocardial rhabdomyosarcoma in multiple neurofibromatosis. Neurology (1981) 0.87
Asthma in managed care. Pediatr Ann (1999) 0.84
Estimating national incidence of group B streptococcal disease: the effect of adjusting for birth weight. Pediatr Infect Dis (1983) 0.83
Impact of the change in polio vaccination schedule on immunization coverage rates: a study in two large health maintenance organizations. Pediatrics (2001) 0.83
Outbreak of poliomyelitis in Gizan, Saudi Arabia: cocirculation of wild type 1 polioviruses from three separate origins. J Infect Dis (1997) 0.83
Parent reports on willingness to accept childhood immunizations during urgent care visits. Pediatrics (1998) 0.83
Mumps surveillance--United States, 1988-1993. MMWR CDC Surveill Summ (1995) 0.83
Giant cell arteritis and polymyalgia rheumatica in a conjugal pair. Arthritis Rheum (1981) 0.82
Preventing neonatal group B streptococcal disease: cost-effectiveness in a health maintenance organization and the impact of delayed hospital discharge for newborns who received intrapartum antibiotics. Pediatrics (1999) 0.82
Measles, mumps, and rubella vaccines. Infect Dis Clin North Am (1990) 0.81
The critical role of population-based epidemiology in cost-effectiveness research. Pediatrics (2000) 0.80
Prevention of Haemophilus influenzae type b infections in day care: a public health perspective. Rev Infect Dis (1986) 0.80
Assessing costs and cost effectiveness of pneumococcal disease and vaccination within Kaiser Permanente. Vaccine (2000) 0.80
Immunogenicity of tetanus-diphtheria toxoids (Td) among Ukrainian adults: implications for diphtheria control in the Newly Independent States of the Former Soviet Union. J Infect Dis (2000) 0.80
Epidemic diphtheria in the Newly Independent States of the Former Soviet Union: implications for diphtheria control in the United States. J Infect Dis (2000) 0.80
Underreporting of pertussis deaths in the United States: need for improved surveillance. Pediatrics (1998) 0.79
Increased immunogenicity of oral poliovirus vaccine administered in mass vaccination campaigns compared with the routine vaccination program in Jordan. J Infect Dis (1997) 0.79